Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

114 results
Display

Role of Clusterin and Tumor Necrosis Factor Receptors on the Apoptosis of Prostate Cancer Cells

Joo KJ

PURPOSE: In prostate cancer, the anti-apoptotic mechanism of sulfated glycoprotein-2 (clusterin) against tumor necrosis factor-alpha (TNF-alpha) receptors and the action of type 2 TNF-alpha receptor (TNFR2) were investigated. MATERIALS AND METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Etanercept in the Treatment of Generalized Annular Pustular Psoriasis

Lo Schiavo A, Brancaccio G, Puca RV, Caccavale

  • KMID: 2434698
  • Ann Dermatol.
  • 2012 May;24(2):233-234.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
TNFalpha and TNFR2 Immunohistochemistry During Ovarian Follicular Development and Atresia in the Rat

Han SR, Son SK, Yang YS, Kim WS

  • KMID: 2224491
  • Korean J Anat.
  • 2005 Dec;38(6):553-559.
Tumor necrosis factor alpha (TNFalpha) is an intraovarian cytokine that may play a role in ovarian development and function. Identification of ovarian TNFalpha receptors provides support for establishing a role...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Tumor Necrosis Factor-alpha Inhibitors-induced Pustular Psoriasis

Park JJ, Lee SC

Anti-tumor necrosis factor (TNF)-alpha agents promise better disease control for the treatment of ankylosing spondylitis resistant to classical disease-modifying treatments. Etanercept, a recombinant human TNF receptor fusion protein, is used...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tumor Necrosis Factor and Regulatory T Cells

Jung MK, Lee JS, Kwak JE, Shin EC

CD4⁺CD25⁺FoxP3⁺ regulatory T (Treg) cells play major roles in the maintenance of immune homeostasis. In this review, we comprehensively describe the relationship between tumor necrosis factor (TNF) and Treg cells,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Psoriasiform Eruption Triggered by Tumor Necrosis Factor-alpha Antagonist Therapy

Choi YJ, Kim DS, Park JM, Oh SH, Park YK, Lee JH

  • KMID: 2248315
  • Korean J Dermatol.
  • 2008 May;46(5):721-723.
Tumor necrosis factor-alpha antagonists include monoclonal antibodies, infliximab, adalimumab, etanercept and golimumab. Clinical trials of these agents have shown that they are remarkably effective for psoriasis, but cutaneous adverse reactions...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Refractory SAPHO Syndrome Treated with Etanercept

Kim YJ, Bae SI, Choi SJ, Lee YH, Ji JD, Song GG

SAPHO syndrome, which has different skin changes and osteoarticular inflammation, is an acronym that stands for synovitis, acne, pustulosis, hyperostosis, and osteitis. Treatment of SAPHO syndrome includes non-steroidal anti-inflammatory drugs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Development of Sarcoidosis During Tumor Necrosis Factor-alpha Antagonist Therapy

Park SY, Kim EK, Hwang DW, Lee KW, Paik SS, Jung KH, Kim TH

Etanercept is a soluble receptor fusion protein that inhibits tumor necrosis factor-alpha(TNF-alpha). The receptor is used widely in the treatment of ankylosing spondylitis, rheumatoid arthritis, sarcoidosis and other indications. For...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Roles of CD137 Signaling in Atherosclerosis

Jung IH, Oh GT

The tumor necrosis factor receptor superfamily (TNFRSF), which includes CD40, LIGHT, and OX40, plays important roles in the initiation and progression of cardiovascular diseases, involving atherosclerosis. CD137, a member of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictive Value of Conjointly Examined IL-1ra, TNF-R I, TNF-R II, and RANTES in Patients with Primary Glomerulonephritis

Zwiech R

Interleukin-1 receptor antagonist (IL-1ra), tumor necrosis factor soluble receptors (sTNF-R) type I and II, and regulated upon activation, normal T-cell expressed and secreted (RANTES) play an important role in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Acute Myeloid Leukemia after Adalimumab Treatment in Psoriatic Arthritis

Min HK, Lee JH, Lee HM, Koh E, Heo JY, Min JK, Park SH

Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-alpha inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New drugs for Rheumatoid arthritis

Seo YI

  • KMID: 2257380
  • Korean J Med.
  • 2009 Jan;76(1):12-17.
Since the late 1990s, based on scientific advancement and biotechnological improvement, many effective drugs such as leflunomide and biologic agents for rheumatoid arthritis (RA) have been developed. These include TNF-alpha...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Differential Signaling via Tumor Necrosis Factor-Associated Factors (TRAFs) by CD27 and CD40 in Mouse B Cells

Woo SY, Park HK, Bishop GA

BACKGROUND: CD27 is recently known as a memory B cell marker and is mainly expressed in activated T cells, some B cell population and NK cells. CD27 is a member...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Macropharge Activation Syndrome Successfully Treated with Combination Therapy Including Etanercept

Sim YS, Kim HS, Kim KN

Macrophage activation syndrome (MAS) is a severe, potentially life-threatening complication of childhood systemic inflammatory disorder, primarily systemic onset juvenile rheumatoid arthritis (SoJRA). It is characterized by pancytopenia, liver insufficiency, coagulopathy,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interstitial Lung Disease That Occurred during Treatment with Etanercept (Enbrel(R)) of Psoriasis Patients

Park SB, Kim HR, Im M, Lee Y, Seo YJ, Lee JH

  • KMID: 2246592
  • Korean J Dermatol.
  • 2013 Sep;51(9):709-712.
Etanercept is widely used to treat autoimmune rheumatic, digestive, and dermatologic diseases such as psoriasis. It acts as a competitive inhibitor of tumor necrosis factor (TNF)-alpha and has acceptable safety...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Incidence of Serious Infection among Rheumatoid Arthritis Patients Exposed to Tumor Necrosis Factor Antagonists

Kim HO, Kang KY, Ju JH, Kim HY, Park SH

  • KMID: 2334912
  • J Korean Rheum Assoc.
  • 2010 Sep;17(3):246-253.
OBJECTIVE: We wanted to investigate the incidence of serious infections among the rheumatoid arthritis (RA) patients who were treated with tumor necrosis factor alpha (TNF-alpha) antagonists. METHODS: We enrolled the 175...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Screening of Genes Regulating TNF-alpha-mediated Synovial Hyperplasia in Rheumatoid Arthritis

Huh SJ, Youn J

  • KMID: 1917148
  • Korean J Phys Anthropol.
  • 2003 Jun;16(2):89-95.
Chronic rheumatoid arthritis (RA) is characterized by the hyperplasia of synovial tissue, which results from the combined influence of the proliferation and antiapoptosis of the synovial cells. In this study,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Expression and Function of the Tumor Necrosis Factor Receptor I (TNFRI), TNFRII, and X-Linked Inhibitor of Apoptosis Genes after Spinal Cord Injury in Rats

Yang JY, Lee JK, Kim KT, Lee HH, Byun BN, Ahn SH

STUDY DESIGN AND OBJECTIVE: Tumor necrosis factor-alpha(TNF-alpha), a key inflammatory mediator, has been demonstrated in spinal cord injury (SCI). However, the expression of TNF receptors following SCI remains to be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytokine profiles in synovial fluid of rheumatoid arthritis

Jeon CH, Kim JH, Park JH, Ahn KS, Kim HJ, Kim EH, Ahn JK, Cha HS, Koh EM

  • KMID: 2252799
  • Korean J Med.
  • 2003 May;64(5):576-587.
BACKGROUND: The assay of cytokines and their soluble receptors in the synovial fluid of inflammatory arthropathy may be useful in studying pathogenetic and immunoregulatory mechanisms of different arthritis. The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis

Lee S, Park YJ, Lee JY

BACKGROUND: Tumor necrosis factor-alpha (TNF-α) inhibitors (TNFis), which are the main treatment for ankylosing spondylitis (AS), have been reported not only to reduce the incidence of anterior uveitis (AU) but...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr